News, videos, social media and more about the recently released MINDACT phase III, prospective randomized trial results
The primary analysis from the MINDACT clinical trial was presented by Martine Piccart, MD, PhD at the American Association for Cancer Research (AACR) annual meeting on Monday, April 18th providing MammaPrint 70-gene assay with the first and only Level 1A clinical utility evidence for chemotherapy benefit. Here is what the oncology community is saying about this data…
ARTICLE LINKS
- AACR Press Release: MammaPrint Genetic Test Can Reduce Use of Post-surgery Chemotherapy Among Early-stage Breast Cancer Patients
- Business Wire Press Release: Agendia’s MammaPrint® First and Only Genomic Assay to Receive Level 1A Clinical Utility Evidence for Chemotherapy Benefit in Early Breast Cancer Patients
- OncLive: 70-Gene Signature Identifies Breast Cancer Subgroup Unlikely to Benefit From Adjuvant Chemo
- Medscape: MammaPrint Shows Which Breast Cancer Patients Can Skip Chemo
- Breast Cancer News: Agendia’s Genomic Risk Assay Cuts Need for Chemotherapy in Early Breast Cancer Patients by 46% in Phase 3 Trial
- GenomeWeb (Premium Article): Agendia Nets Highest Level Evidence for MammaPrint Use to Predict Breast Cancer Chemotherapy Benefit
- The ASCO Post: First Results From MINDACT Confirm the Benefit of Genomic Profiling
- Forbes: MammaPrint, Agendia’s Breast Cancer Test, Is Having A U.S. Moment. Can It Reduce Overtreatment?
- Cancer Therapy Advisor: MammaPrint Test Reduces Use of Adjuvant Chemo Among Patients With Early-stage Breast Cancer
- Clinical Oncology News: Genomic Tool Helps Early Breast Cancer Patients Avoid Chemo: Report from AACR Annual Meeting
VIDEO LINKS
- VIDEO: Healio- Genomic assays have role in determining need for adjuvant chemotherapy – Dr. Adam Brufsky MD, PhD – University of Pittsburgh Medical Center (UPMC)
- VIDEO: Healio- Some women with early-stage breast cancer can safely avoid adjuvant chemotherapy – Dr. Hatem Soliman, MD – Moffitt Cancer Center
- VIDEO: Healio- Gene signature may guide adjuvant chemotherapy use in early-stage breast cancer – Dr. Lajos Pusztai, MD, DPhil – Yale Cancer Center
- VIDEO: ABC7 News (Ft. Myers)- New test may hold chemo-free future for breast cancer patients
- VIDEO: WZZM News (Grand Rapids, MI)- Some breast cancer getting chemotherapy they don’t need
YouTube
Dr. Martine Piccart MD, PhD discusses the MINDACT trial results at AACR 2016
